Semaglutide use in diabetes patients is linked to a higher risk of NAION, a rare eye condition. A Danish-Norwegian study shows a low absolute risk despite significant association.
Novo Nordisk’s Ozempic Potentially Linked To Rare Vision Loss Risk, But Absolute Risk Is Low: Study
